Key Events This Week
21 Sep: Stock opens strong at Rs.127.48 (+2.22%)
22 Sep: New 52-week high reached at Rs.131
23 Sep: Technical momentum signals bullish outlook
25 Sep: Week closes at Rs.124.96 (+1.85%)
21 September 2026: Strong Opening with Positive Momentum
Valiant Laboratories Ltd began the week on a positive note, closing at Rs.127.48, up Rs.2.77 or 2.22% from the previous Friday’s close of Rs.124.71. This gain outpaced the Sensex’s 0.46% rise to 35,787.64 points, signalling early strength in the stock. The volume of 39,916 shares traded indicated healthy investor interest, setting the tone for the week ahead.
22 September 2026: New 52-Week High at Rs.131 Marks a Milestone
On 22 September, Valiant Laboratories Ltd achieved a significant milestone by hitting a new 52-week high of Rs.131 intraday, reflecting a 2.76% increase on the day. The stock closed at Rs.124.51, down 2.33% from the previous day’s close, but the intraday high underscored strong underlying momentum. This peak came after a sustained rally delivering a 12.2% return over the prior four trading sessions, highlighting robust price appreciation within the Pharmaceuticals & Biotechnology sector.
Technical indicators supported this momentum, with the stock trading above all key moving averages (5-day through 200-day), signalling strong technical support. The Mojo Score of 61.0 and an upgraded Mojo Grade to ‘Hold’ from ‘Sell’ as of 19 August 2026 further reflected improved fundamentals and market sentiment.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
23 September 2026: Technical Momentum Signals Bullish Outlook
The stock’s technical momentum shifted decisively towards a bullish stance on 23 September, despite a 1.24% decline in price to Rs.122.96. The weekly Moving Average Convergence Divergence (MACD) indicator turned bullish, signalling strengthening short-term momentum. However, the monthly MACD remained mildly bearish, suggesting some caution for longer-term investors.
The Relative Strength Index (RSI) was bearish on both weekly and monthly charts, indicating potential short-term overbought conditions or consolidation phases. Meanwhile, daily moving averages and Bollinger Bands confirmed a bullish bias, with the stock price remaining above key averages and volatility expanding in favour of upward movement.
Other indicators such as the Know Sure Thing (KST) were bearish weekly, while Dow Theory assessments showed no clear weekly trend but a mildly bullish monthly trend. On-Balance Volume (OBV) was neutral weekly but bullish monthly, suggesting accumulation over the longer term.
24 September 2026: Market Volatility Weighs on Price
On 24 September, Valiant Laboratories Ltd’s price marginally declined by 0.22% to Rs.122.69 amid a sharp Sensex drop of 1.62%. The low trading volume of 2,801 shares reflected subdued market activity. Despite the slight price dip, the stock maintained its position above key moving averages, preserving the underlying bullish technical structure.
Holding Valiant Laboratories Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
25 September 2026: Week Ends on a Positive Note
The stock rebounded on the final trading day of the week, closing at Rs.124.96, up 1.85% from the previous close. This gain contrasted with the Sensex’s modest 0.18% rise to 35,353.29 points, underscoring Valiant Laboratories Ltd’s relative strength. The volume of 8,665 shares traded was moderate, reflecting renewed investor interest as the stock consolidated its gains for the week.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-21 | Rs.127.48 | +2.22% | 35,787.64 | +0.46% |
| 2026-09-22 | Rs.124.51 | -2.33% | 35,672.04 | -0.32% |
| 2026-09-23 | Rs.122.96 | -1.24% | 35,870.78 | +0.56% |
| 2026-09-24 | Rs.122.69 | -0.22% | 35,291.38 | -1.62% |
| 2026-09-25 | Rs.124.96 | +1.85% | 35,353.29 | +0.18% |
Key Takeaways
Positive Signals: Valiant Laboratories Ltd demonstrated resilience by closing the week with a 0.20% gain despite broader market weakness. The new 52-week high at Rs.131 on 22 September marked a significant technical milestone, supported by strong moving averages and bullish weekly MACD. The upgrade to a ‘Hold’ Mojo Grade reflects improved fundamentals and technical momentum.
Cautionary Notes: The bearish RSI on weekly and monthly charts and the mildly bearish monthly MACD suggest potential short-term consolidation or pullbacks. The micro-cap status of the stock implies higher volatility and liquidity risks. Investors should monitor momentum indicators closely for confirmation of sustained strength.
Conclusion
Valiant Laboratories Ltd’s week was characterised by a blend of technical strength and cautious optimism. The stock’s ability to hit a new 52-week high and maintain gains above key moving averages amid a volatile market environment highlights its relative robustness. While short-term momentum indicators show some mixed signals, the overall technical outlook remains positive with a ‘Hold’ rating reflecting a stabilised stance. The stock’s outperformance relative to the Sensex during the week underscores its resilience within the Pharmaceuticals & Biotechnology sector, making it a noteworthy name to watch as momentum indicators evolve.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
